MedPath

BIVALIRUDINA CIPLA 250 MG POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG

BIVALIRUDINA CIPLA 250 MG POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG

Pending
Register Number

81587

Prescription Type

Uso Hospitalario

Authorization Date

Jan 10, 2017

Dosage Form

POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION

Route: VÍA INTRAVENOSA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number81587
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (1)

BIVALIRUDINAActive
Quantity: 250, 00 mg
Name: BIVALIRUDINA

ATC CLASSIFICATION (3)

B01A
B01AE
B01AE06

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.